Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.

Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.

Bibliographic Details
Main Authors:	Sara Lustigman, James P McCarter
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2007-08-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0000076

Similar Items

Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.
by: Mike Y Osei-Atweneboana, et al.
Published: (2011-03-01)

Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
by: Hugues C Nana-Djeunga, et al.
Published: (2014-04-01)

A controlled prospective trial of the prophylactic effect of a single dose of ivermectin against onchocerca volvulus
by: Boussinesq M., et al.
Published: (2001-09-01)

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
by: Sébastien D S Pion, et al.
Published: (2013-01-01)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with <i>Onchocerca volvulus</i>
by: Alfred Dusabimana, et al.
Published: (2020-12-01)

Onchocerca volvulus infection among ivermectin-treated population in a rural setting in Edo State, Nigeria
by: Frederick Olusegun Akinbo, et al.
Published: (2021-01-01)

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
by: Alfred Dusabimana, et al.
Published: (2020-07-01)

A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.
by: Kwablah Awadzi, et al.
Published: (2014-06-01)

Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.
by: Shabnam Jawahar, et al.
Published: (2021-02-01)

The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
by: Fidelis Cho-Ngwa, et al.
Published: (2010-08-01)

Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.
by: Stephen R Doyle, et al.
Published: (2017-07-01)

Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum.
by: John B Patton, et al.
Published: (2018-12-01)

Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
by: Laura Senyonjo, et al.
Published: (2016-08-01)

The mitogenome of Onchocerca volvulus from the Brazilian Amazonia focus
by: James L Crainey, et al.
Published: (2016-01-01)

Oligonucleotide based magnetic bead capture of Onchocerca volvulus DNA for PCR pool screening of vector black flies.
by: Hemavathi Gopal, et al.
Published: (2012-01-01)

Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.
by: Beesan Tan, et al.
Published: (2022-03-01)

Assessing <i>Onchocerca volvulus</i> Intensity of Infection and Genetic Diversity Using Mitochondrial Genome Sequencing of Single Microfilariae Obtained before and after Ivermectin Treatment
by: Shannon M. Hedtke, et al.
Published: (2023-07-01)

Reductions in microfilaridermia by repeated ivermectin treatment are associated with lower Plasmodium-specific Th17 immune responses in Onchocerca volvulus-infected individuals
by: Kathrin Arndts, et al.
Published: (2015-03-01)

Individual exposure to <it>Simulium bites and intensity of Onchocerca volvulus infection</it>
by: Enyong P, et al.
Published: (2010-06-01)

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
by: An Hotterbeekx, et al.
Published: (2020-02-01)

Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice
by: Nathan M. Ryan, et al.
Published: (2021-01-01)

Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
by: Albert Eisenbarth, et al.
Published: (2016-02-01)

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo
by: Saskia I. Johanns, et al.
Published: (2022-05-01)

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
by: Saskia I Johanns, et al.
Published: (2022-05-01)

Preliminary evaluations of 3-dimensional human skin models for their ability to facilitate in vitro the long-term development of the debilitating obligatory human parasite Onchocerca volvulus.
by: Christoph Malkmus, et al.
Published: (2020-11-01)

Interruption of transmission of Onchocerca volvulus in the Southern Chiapas Focus, México.
by: Mario A Rodríguez-Pérez, et al.
Published: (2013-01-01)

A four-antigen mixture for rapid assessment of Onchocerca volvulus infection.
by: Peter D Burbelo, et al.
Published: (2009-01-01)

Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
by: Mohammed A K Mahdy, et al.
Published: (2018-03-01)

Establishment of an in vitro culture system to study the developmental biology of Onchocerca volvulus with implications for anti-Onchocerca drug discovery and screening.
by: Narcisse V T Gandjui, et al.
Published: (2021-02-01)

Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum
by: Adam Hendy, et al.
Published: (2021-11-01)

Urine metabolites for the identification of Onchocerca volvulus infections in patients from Cameroon
by: Vera Wewer, et al.
Published: (2021-08-01)

Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala.
by: Rodrigo J Gonzalez, et al.
Published: (2009-01-01)

Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to <i>Onchocerca volvulus</i> in Mice and Non-Human Primates
by: Nathan M. Ryan, et al.
Published: (2023-07-01)

Optimized strategy for real-time qPCR detection of Onchocerca volvulus DNA in pooled Simulium sp. blackfly vectors.
by: Mary Doherty, et al.
Published: (2023-12-01)

Comparison of structural changes in nodding syndrome and other epilepsies associated with Onchocerca volvulus
by: Mazumder, R, et al.
Published: (2022)

Comparison of Diagnostic Tests for <i>Onchocerca volvulus</i> in the Democratic Republic of Congo
by: An Hotterbeekx, et al.
Published: (2020-06-01)

Significant heterogeneity in Wolbachia copy number within and between populations of Onchocerca volvulus
by: Samuel Armoo, et al.
Published: (2017-04-01)

Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation.
by: Colebunders, R, et al.
Published: (2021)

Development of a preliminary in vitro drug screening assay based on a newly established culturing system for pre-adult fifth-stage Onchocerca volvulus worms.
by: Denis Voronin, et al.
Published: (2019-01-01)

A simple isothermal DNA amplification method to screen black flies for Onchocerca volvulus infection.
by: Andy Alhassan, et al.
Published: (2014-01-01)